Back to top
more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$87.10 USD

87.10
5,960,499

+0.90 (1.04%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $87.11 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Boston Scientific's (BSX) New Buyout to Expand Global Presence

Boston Scientific's (BSX) new acquisition deal is expected to strengthen the company's presence in China.

Perrigo (PRGO) Down 1.5% Since Last Earnings Report: Can It Rebound?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PETQ or BSX: Which Is the Better Value Stock Right Now?

PETQ vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific's (BSX) New Buyout to Expand its Portfolio

Boston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures.

Boston Scientific (BSX) Posts Positive Post-Market Study Data

The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.

Why Is Boston Scientific (BSX) Up 5.6% Since Last Earnings Report?

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PETQ or BSX: Which Is the Better Value Stock Right Now?

PETQ vs. BSX: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights Comcast, Intuit, Boston Scientific, Freeport-McMoRan and Autodesk

Comcast, Intuit, Boston Scientific, Freeport-McMoRan and Autodesk are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Comcast, Intuit & Boston Scientific

Today's Research Daily features new research reports on 16 major stocks, including Comcast Corporation (CMCSA), Intuit Inc. (INTU) and Boston Scientific Corporation (BSX).

Boston Scientific (BSX) Q3 Earnings Miss, Operating Margin Up

Boston Scientific's (BSX) Q3 revenues reflect double-digit organic revenue growth across the majority of its businesses.

Boston Scientific (BSX) Lags Q3 Earnings Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of -2.27% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

The Zacks Analyst Blog Highlights Intuit, Diageo, Sony Group, Southern, and Boston Scientific

Intuit, Diageo, Sony Group, Southern, and Boston Scientific are included in this Analyst Blog.

Mark Vickery headshot

Top Research Reports for Intuit, Diageo & Sony

Today's Research Daily features new research reports on 12 major stocks, including Intuit Inc. (INTU), Diageo plc (DEO) and Sony Group Corp. (SONY).

Earnings Preview: LeMaitre Vascular (LMAT) Q3 Earnings Expected to Decline

LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?

Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Boston Scientific (BSX) Beat Q3 Earnings Estimates?

Boston Scientific's (BSX) top line is likely to have improved with non-COVID elective medical procedures running in a full-fledged way in the United States and across the globe.

Why Boston Scientific (BSX) Could Beat Earnings Estimates Again

Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Boston Scientific (BSX) Benefits From New Buyouts, FX Woes Stay

Boston Scientific's (BSX) organic growth performance is strong across all regions where most of its businesses are growing at the same pace or faster than their competitors in the respective markets.

Here's Why You Should Retain Boston Scientific (BSX) For Now

Investors are optimistic about Boston Scientific's (BSX) impressive top-line results and notable acquisitions.

Haemonetics (HAE) Up 3.2% Since Last Earnings Report: Can It Continue?

Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Boston Scientific's (BSX) WATCHMAN FLX to Offer DAPT in the US

Boston Scientific (BSX) to offer updated labeling for WATCHMAN FLX device after receiving FDA approval.

Boston Scientific (BSX) Grows Operationally Amid Macro Issues

In the Asia Pacific region, Boston Scientific (BSX) grows operationally with notable performance in Japan, India and the ASEAN countries.

General Electric (GE), Boston Scientific Bond Over Heartcare

General Electric's (GE) partnership deal will help the cardiac patients easily avail of heart care treatment.

Boston Scientific (BSX) Signs Obsidio-Acquisition Agreement

Boston Scientific's (BSX) latest acquisition will add the FDA-approved GEM technology to its interventional oncology and embolization portfolio.